However, no cognitive improvement was identified, which probably reflects the limited statistical power and short treatment period of the trial to identify meaningful differences
Always consult with your healthcare provider to tailor these recommendations to your individual needs
Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, et al
This article highlights how CDMOs like ROVI are scaling fast while staying flexible and fully compliant as they adapt to new operational and strategic challenges
The honest summary is that the biology is sound and the early signals are encouraging, but the proof most of us would want, consistent results in robust human trials, is still being built